Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research.
Silo Pharma has raised $11.7M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2026.
Silo Pharma's investors include 32 Ventures.
Silo Pharma is headquartered in Englewood Cliffs, United States.
Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research.
Silo Pharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Silo Pharma — Funding & Investors." VCBacked, July 10, 2026, https://www.vcbacked.co/company/silo-pharma. Accessed August 13, 2026.
VCBacked. (2026). Silo Pharma — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/silo-pharma
{{cite web |title=Silo Pharma — Funding & Investors |url=https://www.vcbacked.co/company/silo-pharma |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated